United States · Bill · HR
H.R. 1919 (113th)
Safeguarding America's Pharmaceuticals Act of 2013
Introduced
9 May 2013
Last action
4 June 2013 · Introduced
Status
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Rep. Latta, Robert E. [R-OH-5], Rep. Matheson, Jim [D-UT-2], Rep. Upton, Fred [R-MI-6], Rep. Dingell, John D. [D-MI-12], Sen. Cassidy, Bill [R-LA], Sen. Blackburn, Marsha [R-TN], Rep. McKinley, David B. [R-WV-1], Rep. Rogers, Mike J. [R-MI-8], Rep. Burgess, Michael C. [R-TX-26], Rep. Shimkus, John [R-IL-15], Rep. Guthrie, Brett [R-KY-2], Rep. Johnson, Bill [R-OH-6], Rep. Schneider, Bradley Scott [D-IL-10], Rep. Olson, Pete [R-TX-22], Rep. Long, Billy [R-MO-7], Rep. Latham, Tom [R-IA-3], Rep. Valadao, David G. [R-CA-22], Rep. Rush, Bobby L. [D-IL-1], Rep. Veasey, Marc A. [D-TX-33], Rep. Walberg, Tim [R-MI-5], Rep. Walorski, Jackie [R-IN-2]
Subjects
Healthcare
Source updated
21 April 2025
Summary
Safeguarding America's Pharmaceuticals Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to establish requirements to facilitate the tracing of drug products through the pharmaceutical supply distribution chain. Requires the Secretary of Health and Human Services (HHS) to establish standards for the exchange of transaction information. Requires the Secretary to establish processes to: (1) provide waivers of requirements for undue economic hardship or emergency medical reasons; (2) provide waivers of requirements relating to product identifiers for prescription drug products packaged without sufficient space to bear the information; and (3) determine other prescription drug products or transactions that should be exempt from the requirements of this Act. Establishes requirements for drug manufacturers, wholesalers, dispensers, and repackagers to ensure that all prior transaction information is provided at each transfer of ownership. Requires such entities to maintain such transaction information for three years. Sets forth exceptions, including for dispensing to a patient and returns. Requires a manufacturer, wholesale distributor, dispenser, repackager, in the event of a recall or for the purpose of investigating a suspect prescription drug product or an illegitimate prescription drug product, to provide within two business days the applicable transaction documentation upon request by the Secretary or other appropriate federal or state official. Requires a manufacturer or repackager to affix or imprint a prescription drug product identifier on each package and homogenous case of a prescription drug product. Requires a manufacturer, wholesale distributor, dispenser, repackager, or third party logistics provider to ensure that each of its trading partners is authorized. Requires a manufacturer, wholesale distributor, dispenser, repackager, and third party logistics provider to implement systems to: (1) investigate suspected illegitimate prescription drug products or, for a third party logistics provider, notify the owner of a need for such an investigation, and (2) handle illegitimate prescription drug products, including through quarantine, disposal, and appropriate notice to the Secretary and, as necessary, trading partners. Requires manufacturers, wholesale distributors, repackagers to verify returned products before further distribution. Requires the Secretary to establish projects and hold public meetings to enhance the safety and security of the pharmaceutical distribution supply chain. Requires the Secretary to issue additional proposed regulations in 2027 to prevent a suspect, illegitimate or counterfeit product, or a product otherwise unfit for distribution from entering into or being further distributed in the supply chain. Requires the Secretary to establish standards for the licensing of wholesale distributors and third party logistics providers. Requires third party logistics providers to be licensed by the state from which the drug is distributed or by the Secretary. Preempts state and local requirements related to tracing drugs through the distribution system, and licensure of wholesale distributors or third party logistics provider licensure. Allows certain prescription drug labeling to be provided solely by electronic means.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 May 2013
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
9 May 2013
Introduced
Introduced in House
Source: IntroReferral
9 May 2013
Introduced
Introduced in House
Source: IntroReferral
10 May 2013
Referred
Referred to the Subcommittee on Health.
Source: Committee
3 June 2013
Floor
Considered under suspension of the rules. (consideration: CR H2968-2984)
Source: Floor
3 June 2013
Floor
Mr. Latta moved to suspend the rules and pass the bill, as amended.
Source: Floor
3 June 2013
Calendars
Placed on the Union Calendar, Calendar No. 65.
Source: Calendars
3 June 2013
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-93.
Source: Committee
3 June 2013
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-93.
Source: Committee
3 June 2013
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
3 June 2013
Passed
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2969-2978)
Source: Floor
3 June 2013
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2969-2978)
Source: Floor
3 June 2013
Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 1919.
Source: Floor
4 June 2013
Introduced
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Referred in Senate · 4 June 2013 · Download file
- Engrossed in House · 3 June 2013 · Download file
- Reported in House · 3 June 2013 · Download file
- Introduced in House · 9 May 2013 · Download file
Documents
10 official files
Referred in Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Referred in Senate (text)
Referred in Senate · EN · 4 June 2013
Referred in Senate (PDF)
Referred in Senate · EN · 4 June 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported in House (text)
Reported in House · EN · 3 June 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported in House (PDF)
Reported in House · EN · 3 June 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (text)
Engrossed in House · EN · 3 June 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (PDF)
Engrossed in House · EN · 3 June 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Passed House amended
summary · EN · 3 June 2013
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 9 May 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (PDF)
Introduced in House · EN · 9 May 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 9 May 2013
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Latta, Robert E. [R-OH-5] · R · Sponsor
- Rep. Matheson, Jim [D-UT-2] · D · Sponsor
- Rep. Upton, Fred [R-MI-6] · R · Sponsor
- Rep. Dingell, John D. [D-MI-12] · D · Sponsor
- Sen. Cassidy, Bill [R-LA] · R · Sponsor
- Sen. Blackburn, Marsha [R-TN] · R · Sponsor
- Rep. McKinley, David B. [R-WV-1] · R · Sponsor
- Rep. Rogers, Mike J. [R-MI-8] · R · Sponsor
- Rep. Burgess, Michael C. [R-TX-26] · R · Sponsor
- Rep. Shimkus, John [R-IL-15] · R · Sponsor
- Rep. Guthrie, Brett [R-KY-2] · R · Sponsor
- Rep. Johnson, Bill [R-OH-6] · R · Sponsor
- Rep. Schneider, Bradley Scott [D-IL-10] · D · Sponsor
- Rep. Olson, Pete [R-TX-22] · R · Cosponsor
- Rep. Long, Billy [R-MO-7] · R · Cosponsor
- Rep. Latham, Tom [R-IA-3] · R · Cosponsor
- Rep. Valadao, David G. [R-CA-22] · R · Cosponsor
- Rep. Rush, Bobby L. [D-IL-1] · D · Cosponsor
- Rep. Veasey, Marc A. [D-TX-33] · D · Cosponsor
- Rep. Walberg, Tim [R-MI-5] · R · Cosponsor
- Rep. Walorski, Jackie [R-IN-2] · R · Cosponsor
- · sshr00 · Standing
- · hsif00 · Standing
Related records
- related to ← Drug Quality and Security Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/113th-congress/house-bill/1919
- Open data entity: https://api.congress.gov/v3/bill/113/hr/1919
- us · 113-hr-1919 · source updated 21 April 2025